. Common terminology relevant to liver progenitor biology. Further details can be found also in (5, 6).
Embryonic liver development
During embryonic development, the liver arises from the definitive endoderm (for reviews on liver development, see (7) (8) (9) ). The definitive endoderm is an embryonic layer, whereas visceral endoderm is a non-embryonic derived layer, also called extra-embryonic endoderm. The definitive endoderm is one of the three germ layers, which include also ectoderm and mesoderm. The definitive endoderm is initially located beneath the ectoderm and mesoderm. In the mouse, the definitive endoderm layer forms a liver bud between E8.5 and E9.5. This layer will also form the pancreas, lung, stomach, intestine, and thyroid. The cardiac mesoderm and septum transversum mesenchyme release signals, such as fibroblast growth factors (FGF) and bone morphogenetic proteins (BMP), which are necessary to induce liver specification. The septum transversum mesenchyme has been implicated to give rise to stellate cells (also called Ito cells), which are fat and vitamin A-storing and extracellular matrix producing liver cells (10) ; cells positive for the Lim-homeobox gene (Lhx2) migrate from the septum transversum into the forming liver bud and become desmin and Lhx2 positive stellate cells. Cells in the developing liver bud are termed hepatoblasts and express alpha-fetoprotein (AFP). Hepatoblasts have been described as bipotential progenitors, developing into mature hepatocytes as well as bile duct epithelial cells (cholangiocytes), based on findings from ex vivo and in vitro studies (11) (12) (13) (14) (15) . Suppression of transcription factor CCAAT-enhancer-binding protein alpha (CEBP ) has been suggested to induce their specification towards biliary differentiation (16, 17) .
Human hepatic progenitors in fetal and adult livers
Different hepatic progenitors in human livers have been described. Based on early findings in developmental biology, hepatic stem cells were originally defined as AFP positive hepatoblasts. More recent research, however, reveals that hepatic stem cells are AFP negative and are the precursors to hepatoblasts (12, 18) . Furthermore, stem cells of assumed mesendodermal origin capable of multilineage differentiation towards liver-and mesenchymal lineages have been discovered (19) . An overview about human hepatic progenitors that have been isolated and characterized is given in Mesenchymal progenitors isolated from adult human livers were investigated for their potential to differentiate into hepatocytes (20, 21) . Mesenchymal-like cells were obtained by selective culture (not sorting) of total liver cells. FACS analyses of cultured cells revealed a phenotype similar to mesenchymal stem cells with positive expression for CD90, CD73, CD29, CD44, CD13, and HLA-class I, but negative expression for CD105, CD133, CD117, CD45, CD34, and HLA-DR; cells were weakly positive for CD49e and CD49b, and only a minor fraction expressed CD49f. When cells were intrasplenically transplanted into uPA + / + -SCID mice, human albumin and AFP positive cells could be observed and human albumin secretion was detected. When transplanted into SCID mice with and without 70% hepatectomy, human albumin gene expression could be measured in mice livers that had undergone hepatectomy, and human albumin positive cells could be detected in mouse liver sections in both models. Potential fusion events were not analyzed. When cells were induced to hepatic lineages in vitro (21) , hepatic functions were increased compared to noninduced controls, but lower than those of freshly isolated adult liver cells.
Hepatic stem cells in the human liver
Hepatic stem cells can be isolated from fetal, neonatal, pediatric, and adult human livers with identical characteristics (12, 18), as described by Schmelzer et al. Cell surface and intracellular markers include CD326, CD133, CD56, E-cadherin, CD29, Patched (24), claudin 3 (18), CK19, and show weak positivity for albumin. Cells are negative for AFP, CD45, CD34, CD38, CD14, CD90, CD235a, VEGFr, vWF, CD31, CD146, desmin, ASMA, transferrin, connexins, PEPCK, DPP4, CYP450; CD117 is variably expressed. Sonic and Indian Hedgehog signaling pathway components are expressed (24) . Stem cells could be selected by MACS sorting as well as under selective culture conditions, which included serum-free medium and culture on plastic. Under these culture conditions, hepatic stem cell colonies formed. These colonies (Figure 1 ) exhibit a typical epithelial morphology of densely packed, small cells with high nucleus-to-cytoplasm ratio. Stem cell colonies are positive for CD326 (Figure 2) , CD44h, CD56, and weakly express albumin, but are negative for AFP.
Cells were capable of self-renewal, as shown by clonogenic expansion for more than 150 population doublings. 0.5 -2.5% of all liver cells from all ages were positive for CD326 expression. Hepatic stem cells have a small diameter of about 9 μm. In vivo, they are located in the ductal plates in fetal and neonatal livers and in the Canals of Hering in pediatric and adult livers. The Canal of Hering has been previously described as the reservoir of stem cells in postnatal livers (25, 26 (12); phase contrast microscopy (A), and fluorescence microscopy (B) of proliferating cells with positive nuclei for incorporated thymidine analog bromodeoxyuridine (B-I) and corresponding total nuclei stained with 4',6-diamidino-2-phenylindole (B-II).
Hepatoblasts in human liver
Hepatoblasts are the main parenchymal cell type of the fetal liver and are defined by their expression of AFP. AFP positive cells are rare in normal adult livers, except in livers with severe injury or disease (30-32) (for review, see (33)). Hepatoblasts can give rise to hepatocytes and cholangiocytes, and are therefore also named bipotential progenitors (15) . AFP-negative hepatic stem cells are the precursors to hepatoblasts that can mature into AFPpositive hepatoblasts (12) . Human fetal hepatoblasts could be cultured long-term and clonally, and contributed to liver parenchyma when transplanted into SCID mice (23) .
Hepatoblasts express biliary and hepatocyte markers such as CK19, CK14, gamma glutamyl transpeptidase, glucose-6-phosphatase, glycogen, albumin, AFP, E-cadherin (34), -1 microglobulin, HepPar1, glutamate dehydrogenase, and dipeptidyl peptidase IV (15, 18) .
Human hepatoblasts do not express the mesenchymal or hematopoietic markers CD90, vimentin, and CD34 (34) . In mice, hepatoblasts express the surface marker Dlk-1 (35-37), which was subsequently demonstrated to be expressed by human fetal hepatoblasts as well (34) . Mouse fetal liver cells sorted for Dlk-1 can be cultured long-term; transplantation of Dlk-1 positive cells into the spleen gives rise to hepatocytes in the liver. Several signaling pathways and transcription factors contribute towards differentiation into either cell type. In mice, Notch signaling controls differentiation towards biliary epithelium by upregulation of HNF1 but downregulation of HNF1 , HNF4, and C/EBP (38) , and, in turn, suppression of C/EBP expression in periportal hepatoblasts is suggested to induce biliary epithelial differentiation by increasing HNF6 and HNF1 expression (17). 
Murine and rat hepatic progenitors in the fetal and adult liver
Various surface markers have been applied to identify hepatic stem or progenitor populations in rodents. (35) demonstrated that fetal mouse liver epithelial cells positive for AFP or E-cadherin did not express hematopoietic stem cell markers CD34, CD117, Ter119, or CD45, but were positive for progenitor markers Sca-1 and Pancytokeratin. Both E-cadherin positive sorted as well as unsorted fetal liver cell fractions from wild type mice gave rise to liver parenchyma when transplanted into retrorsine treated DPPIV -/ -mice.
As described for human hepatoblasts above, mouse fetal liver hepatoblasts have been shown to express the surface marker Dlk-1 (35-37). Dlk-1 positive sorted mouse fetal liver cells can be cultured long-term and, when transplanted into the spleen, give rise to hepatocytes in the liver. Dabeva et al. (52) described the re-population potential of wild type fetal rat liver cells when transplanted into DPPIV -/ -rat models. These models included knockouts that had undergone two-third partial hepatectomy and were either treated with retrorsine or not. In rats treated with retrorsine, which blocked proliferation of endogenous hepatocytes, mainly bipotential, transplanted progenitors were observed expressing AFP, albumin, and CK19. In non-treated rats, transplanted cells expressed mainly either hepatocytic or biliary markers.
The positive expression of aldehyde dehydrogenase (ALDH) has been used as a feature to select progenitors from adult mouse liver (53) . ALDH + cells were shown to have stem cell characteristics and to express markers of human hepatic stem cells such as CD326, CK19, CD133, and Sox9.
Various hepatic progenitor cell lines have been developed from normal, genetically modified, or toxin treated rodents (54) (55) (56) (57) (58) (59) (60) (61) (62) . Several of these lines were described as bipotential in vitro or when transplanted in vivo.
Oval cells
Oval cells were first described in rodents, emerging when the liver is exposed to certain toxins (for review, see (63)) (64) . Termed "oval cells" because of their oval shaped nucleus, these small cells have a diameter of less than 10 μm. They are located near the portal triads and expand in the livers of animals exposed to oncogenic insults. The term "oval cells" frequently refers to liver stem cells or progenitors. However, oval cells can be distinguished from normal hepatic progenitors phenotypically and in their growth regulatory requirements (65) . Several protocols have been shown to lead to the emergence of oval cells: administration of 2-acetylamino fluorine or dipin in combination with partial hepatectomy; administration of carbon tetrachloride, 3-methyl-diaminobenzidine, galactosamine, furane, or 3,5-diethoxycarbonyl-1,4-dihydrocollidine; etluonine addition to a choline-deficient diet; or transgenic albumin-urokinase-type plasminogen-activator mice.
Oval cells were described as positive for several surface and intracellular markers (including hematopoietic and mesenchymal markers not found on normal epithelial hepatic stem cells) such as CD34 (66), CD117 (67), AFP, CK14, CK19 (68), GGT, OC.2, OV-6, and CD90 (69). CD90, however, was subsequently demonstrated to be expressed not by oval cells but by myofibroblasts (70) .
Some primary liver tumors are suggested to emerge from oval cells (71) .
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Hepatic progenitors found in various mammalian species
Few data have been published on hepatic progenitors from species other than human or rodent. In general, pigs are used as an animal model closely resembling human physiology and metabolic functions. This makes the pig model more favorable than the rodent model. However, this model is scarcely used due to obvious constraints in keeping animals. Kano et al. (72, 73) investigated hepatic progenitors isolated by culture selection from nonparenchymal liver cell suspensions of six-seven months old pigs. Cell clusters in culture were positive for the hepatic markers AFP, albumin, transferrin, CK18, CK7, and c-met, but did they not express biliary markers such as gamma-glutamyltransferase, CK19, and CK14, although they were positive for oval cell marker OV6. Duct-like structures emerged from clusters expressing biliary epithelial markers. Clonal cell growth could be established (74) . Comparable cells could be obtained (75) by isolating small liver cells from pigs that had undergone partial hepatectomy. In addition to the hepatic markers albumin and AFP, these cells also expressed biliary marker CK19 and were positive for OV6. In culture, cells were positive for stem-cell factor, CD117, CD90, AFP, CK19, and OV6. Fetal porcine liver cells were used to establish colonies of pluripotent progenitors (76, 77).
Extra-hepatic sources of potential liver progenitors
Several extra-hepatic sources have been described to harbor progenitors able to differentiate into hepatic lineages in vitro and in vivo. It is widely debated whether cells of extra-hepatic origin are able to differentiate into hepatic cell types or if they fuse with the recipient's liver cells when transplanted. Tissue sources include bone marrow, adipose tissue, umbilical cord, and peripheral blood. Hepatic differentiation potentials of embryonic stem cells (ESC), placenta derived stem cells, or induced pluripotent stem cells (iPS cells) are not discussed here; further literature can be found in reviews (78) (79) (80) (81) (82) .
Bone marrow cells or bone marrow derived hematopoietic stem cells have been suggested to be able to trans-differentiate into hepatic lineages. Petersen et al. performed initial experiments with cross-strain and cross-sex bone marrow and liver transplantations in rats (83) . When male bone marrow was transplanted into female recipients and liver damage was induced, Y-chromosome positive cells could be detected in the female livers. Also, when male dipeptidyl peptidase (DPPIV) positive bone marrow was transplanted into female DPPIV negative recipients and liver damage was induced, DPPIV positive cells could be detected in the female livers. A further approach included transplantations of major histocompatibility complex class II L21-6 isozyme negative whole livers into positive enzyme expressing rats; after induction of liver damage, positive enzyme expressing cells could be detected. (116) , which were CD29, CD44, CD71, CD90, CD106, CD120a, and CD124. Culture selected clonal bone marrow derived MSCs expressed mesenchymal cellspecific markers (e.g. CD13, CD29, CD44, and CD90), and were negative for hematopoietic markers such as CD3, CD14, CD34, and CD45 (100). When transplanted in SCID mice, nonfused human cells could be detected in the liver. Adipose tissue derived stem cells were described to differentiate into hepatic lineages (109) (110) (111) (112) (113) (114) (115) . Adipose tissue derived MSCs were characterized to potentially express CD9, CD13, CD29, CD44, CD49d, CD54, CD73, CD90, CD105, CD146, CD166, osteopontin and osteonectin, and to be negative for hematopoietic and endothelial markers such as CD45, CD34 and CD31. Marker expressions and hepatic potential are further summarized in current reviews (117, 118) . In general, most in vivo transplantation studies using MSCs did not exclude donor cell fusion with host cells. Only one study (Aurich et al. (112) ) demonstrated the integration of non-fused human adipose MSCs in the livers of mice that had undergone combined toxin induced liver damage and hepatectomy.
Lee et al. (119) transplanted green fluorescent protein mouse gallbladder epithelial cells into non-fluorescent SCID mice that had undergone retrorsine treatment and either partial hepatectomy before transplantation or carbon tetrachloride treatment following transplantation. Within one to four months after transplantation, green fluorescent protein positive cells could be detected within the recipient mice. These cells expressed mostly biliary markers, but cells positive for hepatic markers could be detected as well. (107, 123, 124) .
Conclusively, it appears that extra-hepatic progenitors integrate into the liver only to a very minor percentage and only when severe liver damage is induced. The majority of these events appear to be due to fusion and not differentiation. The observed improvements of liver functions by mesenchymal cells could be attributed to their secretion of growth factors and cytokines and immunosuppressive properties (111, (125) (126) (127) .
Conclusion
Although there is still some debate about the detailed characteristics that identify hepatic progenitors, much progress has been achieved during recent years in defining, isolating, characterizing, and transplanting various types of progenitors. This is especially the case for hepatic progenitors isolated from human livers. Hepatic progenitors represent a population with potential advantages over total liver cell suspensions or hepatocytes for cell transplantation in patients (29, 128) , for review see (129) . Because of their high proliferation and differentiation potential a major advantage for transplantation of stem cells over total liver cell suspensions would be the requirement for less cell numbers to inject, which would decrease the risks associated with transplanting high cell numbers. In addition, because of their proliferation and differentiation potential, progenitors could be used in applications such as extracorporeal liver support systems (130, 131) , and may be used as an alternative cell source in pharmacological screening models. Cultures of progenitors also provide an easy in vitro tool to study principles of developmental biology. 
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